JP2001039976A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001039976A5 JP2001039976A5 JP2000151138A JP2000151138A JP2001039976A5 JP 2001039976 A5 JP2001039976 A5 JP 2001039976A5 JP 2000151138 A JP2000151138 A JP 2000151138A JP 2000151138 A JP2000151138 A JP 2000151138A JP 2001039976 A5 JP2001039976 A5 JP 2001039976A5
- Authority
- JP
- Japan
- Prior art keywords
- compound according
- active ingredient
- preventing
- agent
- prophylactic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000151138A JP2001039976A (ja) | 1999-05-24 | 2000-05-23 | 縮合複素環化合物の塩酸塩 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP14351399 | 1999-05-24 | ||
| JP11-143513 | 1999-05-24 | ||
| JP2000151138A JP2001039976A (ja) | 1999-05-24 | 2000-05-23 | 縮合複素環化合物の塩酸塩 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2001039976A JP2001039976A (ja) | 2001-02-13 |
| JP2001039976A5 true JP2001039976A5 (enExample) | 2007-07-12 |
Family
ID=26475217
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000151138A Ceased JP2001039976A (ja) | 1999-05-24 | 2000-05-23 | 縮合複素環化合物の塩酸塩 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2001039976A (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI1679074T1 (sl) | 2003-10-24 | 2011-04-29 | Santen Pharmaceutical Co Ltd | Terapevtsko sredstvo za keratokonjuktivno motnjo |
| KR20060118520A (ko) | 2003-10-29 | 2006-11-23 | 산텐 세이야꾸 가부시키가이샤 | 각결막장해 치료제 |
| TW200637856A (en) | 2005-01-24 | 2006-11-01 | Sankyo Co | Process for producing thiazolidinedion compound and intermediate thereof |
| JP2006225382A (ja) * | 2005-01-24 | 2006-08-31 | Sankyo Co Ltd | チアゾリジンジオン化合物の製造方法及びその製造中間体 |
| US8148389B2 (en) | 2005-11-28 | 2012-04-03 | Senju Pharmaceutical Co., Ltd. | Pharmaceutical comprising PPAR agonist |
| JP2008044932A (ja) * | 2006-07-21 | 2008-02-28 | Daiichi Sankyo Co Ltd | チアゾリジンジオン化合物を含有する組成物 |
| WO2008026668A1 (en) * | 2006-08-31 | 2008-03-06 | Daiichi Sankyo Company, Limited | Medicinal composition containing insulin resistance improving agent |
| WO2008143254A1 (ja) | 2007-05-21 | 2008-11-27 | Senju Pharmaceutical Co., Ltd. | PPARδアゴニスト含有医薬 |
-
2000
- 2000-05-23 JP JP2000151138A patent/JP2001039976A/ja not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002244860B2 (en) | Treatment of type 2 diabetes with inhibitors of dipeptidyl peptidase IV | |
| JP2008007519A5 (enExample) | ||
| RU2001131722A (ru) | 5-[4-(6-Метокси-1-метил-1Н-бензимидазол-2-илметокси)бензил]-тиазолидин-2,4 -ди он гидрохлорид, обладающий гипогликемической активностью | |
| JP2003501361A5 (enExample) | ||
| AU2002244860A1 (en) | Treatment of type 2 diabetes with inhibitors of dipeptidyl peptidase IV | |
| TWI255817B (en) | Glucopyranosyloxybenzylbenzene derivatives and medicinal use thereof | |
| JP2010530431A5 (enExample) | ||
| JP2006502187A5 (enExample) | ||
| JP2007533722A5 (enExample) | ||
| CN101772346A (zh) | 用于降低治疗副作用的方法和组合物 | |
| EP1806347A4 (en) | PYRIMIDINE DERIVATIVES FUSED WITH AN AROMATIC RING | |
| WO2009127974A3 (ko) | 심혈관계 질환 치료용 약제학적 제제 | |
| MXPA03006217A (es) | Sistema de administracion espaciada de farmacos. | |
| JP2007533733A5 (enExample) | ||
| HK1053058A1 (zh) | 普拉克索用於治疗成瘾性疾病的用途 | |
| JP2005526696A5 (enExample) | ||
| JP2004508399A5 (enExample) | ||
| JP2001039976A5 (enExample) | ||
| US20160287549A1 (en) | Novel methods for treating neurodegenerative diseases | |
| JP2002508372A5 (enExample) | ||
| BR112019026029A2 (pt) | Formulações farmacêuticas orais de remogliflozina | |
| JP2002537246A5 (enExample) | ||
| JP2007538102A5 (enExample) | ||
| JPH09118624A5 (enExample) | ||
| CA2341949A1 (en) | Novel compounds for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses |